PDE5A and diabetes mellitus: Our results challenge this assumption and indicate that HbA1c should be measured in all relevant trials, especially since endpoints like erectile dysfunction could be affected by diabetes severity and almost 1/4 of all patients with diabetes are prescribed PDE5 inhibitors.8